Search results for

A newly published study out of the University of Idaho suggests that the higher perceived risk of a disease, the more likely someone is to vaccinate.

Regeneron — the pharmaceutical company developing COVID-19 treatments — has received FDA approval for the first drug aimed at another infectious disease that's been in the headlines.

With Election Day two weeks away and early voting in full swing, NPR answers listener questions about voting dos and don'ts this year.

The British government has announced plans for a coronavirus vaccine challenge trial: Volunteers will receive an experimental vaccine and then be deliberately exposed to the coronavirus.

NPR's Ari Shapiro speaks with Richard Hasen, a law professor at the University of California, Irvine, about various election cases and lawsuits two weeks before Election Day.

The pandemic continues to exact a heavy emotional toll on health care workers, says Kimberly Johnson, who provides them with free therapy. "I wish people knew ... what I saw," clients tell her.

NPR's Rachel Martin talks to Aimee Allison of She the People, a group elevating the political power of women of color, about Sen. Kamala Harris suspending her Democratic presidential campaign.

NPR's Steve Inskeep talks to House Intelligence Committee Chairman Adam Schiff about his committee's report that could serve as the basis for articles of impeachment against President Trump.

While President Trump has downplayed the threat of foreign interference in voting, his administration has been applauded by election officials and others for working to secure the 2020 elections.

New York Times Magazinewriter Emily Bazelon says false content moves through the Internet unchecked — undermining the political process along the way: "Lies often go viral faster than truth."